Dr. Jan Casselman, PhD[email protected]Clinical NewsMaking the invisible, visible: Meeting EU requirements on doseImplementing an effective dose management system will help hospitals meet the new European Union legislative requirements and enable radiologists to meet their ethical responsibility to maximize patient safety, writes Dr. Jan Casselman.March 19, 2014Page 1 of 1Top StoriesMolecular ImagingF-18 PSMA PET-CT proves clinical value in prostate cancerF-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.Molecular ImagingCombined PET scans predict progression of Alzheimer’sMolecular ImagingPET scans predict outcomes for patients undergoing CAR T-cell therapyMRIMRI-based nomogram provides boost in breast cancerCTCT estimated to cause 5% of new cancer cases